High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis
- PMID: 16387946
- DOI: 10.1183/09031936.06.00037005
High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis
Abstract
The aim of this prospective study was to determine the prevalence and characteristics of acid gastro-oesophageal reflux (GER) in patients with idiopathic pulmonary fibrosis (IPF). Sixty-five consecutive patients with well-defined IPF were subjected to 24-h pH monitoring and oesophageal manometry. A total of 133 consecutive patients with intractable asthma and symptoms of GER were used as comparisons. The prevalence of abnormal acid GER in IPF patients was 87%, with 76% and 63% demonstrating abnormal distal and proximal oesophageal acid exposures, respectively. Abnormal acid GER was significantly more common in IPF patients than asthma patients. Only 47% of IPF patients experienced classic GER symptoms. Despite treatment with standard doses of proton pump inhibitors (PPIs), 12 out of 19 patients receiving PPIs during the 24-h pH monitoring had abnormal oesophageal acid exposures by pH probe. There was no correlation between IPF severity and acid GER severity. In conclusion, abnormal acid gastro-oesophageal reflux is highly prevalent, but often clinically occult in patients with idiopathic pulmonary fibrosis. Standard doses of proton pump inhibitors may not suppress the acid gastro-oesophageal reflux in this population. Therefore, further studies are needed to determine if acid abnormal gastro-oesophageal reflux represents an important risk factor for idiopathic pulmonary fibrosis development or progression, and if optimal suppression of acid gastro-oesophageal reflux slows the progression of idiopathic pulmonary fibrosis and/or decreases episodic exacerbations of idiopathic pulmonary fibrosis.
Comment in
-
High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis.Eur Respir J. 2006 Oct;28(4):884-5; author reply 885. doi: 10.1183/09031936.06.00071806. Eur Respir J. 2006. PMID: 17012636 No abstract available.
Similar articles
-
Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.Am J Respir Crit Care Med. 1998 Dec;158(6):1804-8. doi: 10.1164/ajrccm.158.6.9804105. Am J Respir Crit Care Med. 1998. PMID: 9847271
-
Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.Aliment Pharmacol Ther. 2004 Sep 15;20(6):637-43. doi: 10.1111/j.1365-2036.2004.02127.x. Aliment Pharmacol Ther. 2004. PMID: 15352912
-
Gastro-oesophageal reflux and interstitial lung disease.Dig Liver Dis. 2006 Dec;38(12):879-84. doi: 10.1016/j.dld.2006.05.012. Epub 2006 Jul 7. Dig Liver Dis. 2006. PMID: 16824811
-
Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.Aliment Pharmacol Ther. 2006 Mar;23 Suppl 1:25-32. doi: 10.1111/j.1365-2036.2006.02802.x. Aliment Pharmacol Ther. 2006. PMID: 16483267 Review.
-
Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease and the role of night-time gastro-oesophageal reflux.Aliment Pharmacol Ther. 2004 Dec;20 Suppl 9:26-38. doi: 10.1111/j.1365-2036.2004.02253.x. Aliment Pharmacol Ther. 2004. PMID: 15527462 Review.
Cited by
-
The bacterial microbiota in inflammatory lung diseases.Clin Immunol. 2015 Aug;159(2):177-82. doi: 10.1016/j.clim.2015.05.022. Epub 2015 Jun 26. Clin Immunol. 2015. PMID: 26122174 Free PMC article. Review.
-
Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.Respir Med. 2016 Oct;119:96-101. doi: 10.1016/j.rmed.2016.08.028. Epub 2016 Aug 31. Respir Med. 2016. PMID: 27692155 Free PMC article.
-
Diagnosis of idiopathic pulmonary fibrosis: Current issues.Intractable Rare Dis Res. 2015 May;4(2):65-9. doi: 10.5582/irdr.2015.01009. Intractable Rare Dis Res. 2015. PMID: 25984423 Free PMC article. Review.
-
Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.Am J Respir Crit Care Med. 2016 Jun 15;193(12):1345-52. doi: 10.1164/rccm.201512-2316PP. Am J Respir Crit Care Med. 2016. PMID: 27110898 Free PMC article. Review.
-
Epidemiology and management of common pulmonary diseases in older persons.J Gerontol A Biol Sci Med Sci. 2012 Mar;67(3):276-91. doi: 10.1093/gerona/glr251. Epub 2012 Feb 15. J Gerontol A Biol Sci Med Sci. 2012. PMID: 22337938 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical